Myocardial Infarction Mi clinical trials

Explore recruiting myocardial infarction mi clinical trials.

Recruiting myocardial infarction mi studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Myocardial Infarction Mi trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effect of impact of PCSK9 inhibitor on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular disease needing coronarography.

France

Therapeutic exploratory (Phase II) EU CTIS Study details

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects with End Stage Kidney Disease Undergoing Dialysis

Hungary, Germany, Sweden, Belgium, Austria, Bulgaria +16 more

Phase II and Phase III (Integrated) EU CTIS Study details

Prolonged corticosteroid therapy in scheduled cardiac surgery in intermediate/high-risk patients: a prospective multicenter randomized controlled double-blind placebo-controlled study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event

Greece, Hungary, Poland, Germany, Slovakia, Denmark +7 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

J2A-MC-GZGS: A Phase 3, Open-Label Study of Once Daily Orforglipron Compared with Insulin Glargine in Adult Participants with Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4)

Greece, Germany, Austria, Romania, Slovakia, Czechia +2 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Myocardial Infarction Mi trials by city

Myocardial Infarction Mi clinical trials

Recruiting myocardial infarction mi studies right now

Performance of Coronary CT Angiography to Rule Out Coronary Artery Disease After Out-of-hospital Cardiac Arrest

Diagnostic Accuracy of ECG-less Gated Cardiac CT in Resuscitated Cardiac Arrest Survivors Without ST Elevation Myocardial Infarction

STEMI Treated With a Polymer-free Sirolimus-coated Stent and P2Y12 Inhibitor-based SAPT Versus Conventional DAPT

The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field

Human Embryonic Stem Cell-Derived Cardiomyocyte Therapy for Chronic Ischemic Left Ventricular Dysfunction

Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI

Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute Myocardial Infarction

Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPTURE AMI Study

Stellate Ganglion Morphine Infiltration on Myocardial Ischemia-Reperfusion Injury

No-Reflow in Patients With STEMI After Intracoronary Tirofiban After Opening of the Track

Non-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)

Low-dose Interleukin-2 After Myocardial Infarction to Investigate Effects on Tissue-resident Regulatory T Cells

Also recruiting in Europe

Effect of impact of PCSK9 inhibitor on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular disease needing coronarography.

VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (VERONICA)

A Phase 2b/3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Combined Dose-Finding and Cardiovascular Outcome Study to Investigate the Efficacy and Safety of CSL300 (Clazakizumab) in Subjects with End Stage Kidney Disease Undergoing Dialysis

Prolonged corticosteroid therapy in scheduled cardiac surgery in intermediate/high-risk patients: a prospective multicenter randomized controlled double-blind placebo-controlled study

A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Effect of AZD0780 on Major Adverse Cardiovascular Events in Patients with Established Atherosclerotic Cardiovascular Disease (ASCVD) or at High Risk for a First ASCVD Event

J2A-MC-GZGS: A Phase 3, Open-Label Study of Once Daily Orforglipron Compared with Insulin Glargine in Adult Participants with Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk (ACHIEVE-4)

Myocardial Infarction Mi trials by city

Other conditions